Humira is a medicine used to treat certain types of arthritis and inflammatory bowel diseases. It works by stopping a substance called TNF-alpha from causing inflammation in the body. This helps reduce pain and swelling.
Every report comes from a Lived member, sent anonymously.
Have you tried Humira (Adalimumab) for Rheumatoid Arthritis?
Adalimumab, best known as Humira, is an injectable biologic (a protein medicine made in living cells) for long-term inflammatory diseases driven by the immune system. In adults it treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (inflammatory arthritis of the spine), Crohn's disease, ulcerative colitis and plaque psoriasis, mostly when the disease is moderate to severe. It also treats hidradenitis suppurativa, painful recurring lumps in skin folds, from age 12, and some types of non-infectious uveitis, inflammation inside the eye. Children can also take it for juvenile idiopathic arthritis, Crohn's disease, ulcerative colitis or uveitis. In ulcerative colitis, US gastroenterology guidance ranks it among the less effective advanced treatments (biologics and similar targeted drugs used when standard treatment falls short), so other options are often tried first. Biosimilars such as Amjevita and Cyltezo are highly similar versions of the same antibody, with their own devices and instructions.
Tumor necrosis factor alpha (TNF-alpha) is a signaling protein the immune system uses to drive inflammation. In rheumatoid arthritis and related diseases, high levels in the joints fuel both inflammation and joint damage. Adalimumab is a lab-made antibody that binds TNF-alpha and stops it from acting on cells. This can ease pain, swelling and other symptoms, and in rheumatoid arthritis it slows joint damage seen on X-rays, although exactly how the blockade produces each benefit is not fully understood. Because TNF-alpha also helps fight infection, blocking it is the source of the drug's main risks.
Adalimumab is a shot under the skin from a single-use pen or prefilled syringe, which most people learn to give themselves at home. Adults with arthritis typically inject every other week. Crohn's disease, ulcerative colitis and hidradenitis suppurativa start with larger doses over the first two weeks, and hidradenitis suppurativa then continues weekly or every other week. Children's doses are based on weight. Humira is kept in the refrigerator and never frozen; for travel it can stay at room temperature (up to 77°F) for up to 14 days, then is discarded. Some Humira needle covers may contain latex, a concern with latex allergy.
Redness, itching, pain or swelling where the needle goes in is most common and usually fades within a few days. Headaches, rash, colds and sinus infections are also somewhat more frequent. Serious infection is the main concern, so call the care team right away for fever, chills, a cough that will not go away, unexplained weight loss or painful red skin. Trouble breathing or swelling of the face, eyes, lips or mouth after a dose can signal a serious allergic reaction and needs 911. Less often, it affects the liver, blood counts or nerves; report yellowing skin or eyes, unusual bruising or new numbness right away.
Humira carries a boxed warning, the strongest US drug warning, for serious infections, including tuberculosis (TB). Risk is higher after 65 and with steroids or methotrexate (an immune-suppressing drug often used for arthritis). People are tested for TB and hepatitis B first, because both can reactivate, and TB can still develop after a negative test. It is not started during an active infection. The warning also covers lymphoma (a cancer of immune cells) and other cancers, a risk weighed most carefully in young people. A rare lymphoma, fatal in reported cases, has occurred mostly in teen and young adult males with Crohn's disease or ulcerative colitis who also took azathioprine or mercaptopurine (immune-suppressing pills). Adults also have somewhat more lymphoma and skin cancers other than melanoma, so mention any sore that does not heal. It is not combined with other biologics, such as another TNF blocker or abatacept (Orencia). Live vaccines are avoided. If you are pregnant or planning to be, ask about continuing it; a baby exposed late in pregnancy needs its doctor told before any vaccines. Heart failure and multiple sclerosis can start or worsen, so both need discussion first, and new swollen ankles or breathlessness should be reported.
How soon adalimumab helps depends on the condition. In arthritis, people often start to feel better over 2 to 12 weeks. In psoriasis studies, skin clearing was measured at 16 weeks, and in adults with ulcerative colitis it is usually stopped if remission (symptoms largely settled) has not come by week 8. The care team uses follow-up visits at points like these to decide whether it is working. Not everyone responds, and some people form antibodies against the drug, which can make it work less well; in rheumatoid arthritis, methotrexate alongside it makes this much less likely. For people who respond, it is usually long-term treatment, with regular check-ups and blood tests.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Humira (Adalimumab), what you've noticed, or ask the community a question.